Monogenic Diabetes
9
5
5
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (9)
Application of FreeStyle Libre 2 for Evaluating Glycemic Variability Characteristics in Patients With Extreme Glucose Metabolism Phenotypes
Glucokinase Activator in Monogenic Diabetes
China Monogenic Diabetes Registry
Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE)
Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study
Screening and Molecular Diagnosis-based Individualized Precision Management of Monogenic Diabetes
Monogenic Diabetes Misdiagnosed as Type 1
Identifying Maturity-onset Diabetes of the Young in Emirati Patients
Incretin Regulation of Insulin Secretion in Monogenic Diabetes